Oaktree is a leader among global investment managers specializing in alternative investments, with over $220 billion in assets under management. The firm emphasizes an opportunistic, value-oriented, and risk-controlled approach to investments in credit, equity, and real estate. Oaktree is a leading provider of debt and royalty financing for the global life sciences industry.
